The World Health Assembly (WHA), the decision-making body of WHO, held the 67th session on 19–24 May 2014. It was attended by delegations from all WHO Member States including Ghana. AMR was on  agenda as prepared by the Executive Board. 

In view of the current developments in Ghana on AMR, Ghana made the following statement at the 67th WHA.

Links: 67th World Health Assembly [Courtesy WHO website]

Statement by Ghana

Mr. Chairman,
Ghana has the honour to make this statement on behalf of the 47 Member States of the AFRO Region. We would like to commend the Secretariat for the report before us as well as the timely release of the Global Report on Surveillance. Antimicrobial medicines have significantly reduced mortality from infectious diseases over the years.

However, misuse and overuse of antimicrobials in both human and animals have increasingly raised levels of antimicrobial resistance in combating pathogens.The antimicrobial agents pipeline is lean especially for antibiotics and diagnostics and although vaccines exists, they are insufficient to fill the gap being created by the loss of existing medicine through resistance. Infections caused by drug-resistant pathogens do not only increase mortality across all settings, but also lead to prolonged stays in hospital and increased risk of admission to intensive care units and hence increases in the health bill. The growing prevalence of Antimicrobial drug resistance poses a formidable challenge to global health security, especially for countries with nascent surveillance and weak laboratory capacity. As the report rightly notes, AMR threatens the long-term sustainability of the public health control of many communicable diseases, including tuberculosis, malaria and HIV/AIDS. This is particularly worrisome and calls for greater global efforts and solidarity in addressing this looming public health menace.

Mr. Chairman,
It is encouraging to note that a number of countries have developed national action plans or strategies to counter the threat of AMR. We urge all Member States, who are yet to do so, to commit themselves to develop a comprehensive national plan through a multi-sectoral approach. We also share the need for countries to strengthen regulatory mechanisms to maintain and support innovation

Ghana National Drugs Programme, Ministry of Health (GNDP MOH) 2015